Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

CELL THERAPY

Orthotopic editing of T-cell receptors

Nature Biomedical Engineering volume 3, pages 949–950 (2019)Cite this article

Subjects

The simultaneous removal of endogenous T-cell receptor α-chains and β-chains, and the orthotopic placement of an exogenous receptor in human T cells via CRISPR gene-editing, prevents the mispairing between endogenous and transgenic receptors while preserving the cells’ function.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: T-cell engineering for the generation of therapeutic T cells.

References

  1. Debets, R., Donnadieu, E., Chouaib, S. & Coukos, G. Semin. Immunol. 28, 10–21 (2016).

    Article  CAS  Google Scholar 

  2. Robbins, P. F. et al. Clin. Cancer Res. 21, 1019–1027 (2015).

    Article  CAS  Google Scholar 

  3. Rapoport, A. P. et al. Nat. Med. 21, 914–921 (2015).

    Article  CAS  Google Scholar 

  4. Willemsen, R. A. et al. Gene Ther. 7, 1369–1377 (2000).

    Article  CAS  Google Scholar 

  5. Bendle, G. M. et al. Nat. Med. 16, 565–570 (2010).

    Article  CAS  Google Scholar 

  6. Ahmadi, M. et al. Blood 118, 3528–3537 (2011).

    Article  CAS  Google Scholar 

  7. Gallegos, A. M. et al. Nat. Immunol. 17, 379–386 (2016).

    Article  CAS  Google Scholar 

  8. Fraietta, J. A. et al. Nature 558, 307–312 (2018).

    Article  CAS  Google Scholar 

  9. Schober, K. et al. Nat. Biomed. Eng. https://doi.org/10.1038/s41551-019-0409-0 (2019).

  10. Govers, C., Sebestyén, Z., Coccoris, M., Willemsen, R. A. & Debets, R. Trends Mol. Med. 16, 77–87 (2010).

    Article  CAS  Google Scholar 

  11. Eyquem, J. et al. Nature 543, 113–117 (2017).

    Article  CAS  Google Scholar 

  12. Legut, M., Dolton, G., Mian, A. A., Ottmann, O. G. & Sewell, A. K. Blood 131, 311–322 (2018).

    Article  CAS  Google Scholar 

  13. Roth, T. L. et al. Nature 559, 405–409 (2018).

    Article  CAS  Google Scholar 

  14. Leong, W., Nankervis, B. & Beltzer, J. Cell Gene Ther. Insights 4, 679–694 (2018).

    Article  Google Scholar 

  15. Hammerl, D., Rieder, D., Martens, J. W. M., Trajanoski, Z. & Debets, R. Trends Immunol. 39, 921–936 (2018).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratory of Tumor Immunology, Department of Medical Oncology, Erasmus MC-Cancer Institute, Rotterdam, The Netherlands

    Dian Kortleve, Dora Hammerl & Reno Debets

Authors
  1. Dian Kortleve
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dora Hammerl
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Reno Debets
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Reno Debets.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kortleve, D., Hammerl, D. & Debets, R. Orthotopic editing of T-cell receptors. Nat Biomed Eng 3, 949–950 (2019). https://doi.org/10.1038/s41551-019-0490-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41551-019-0490-4

Search

Advanced search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer